Publications by authors named "Marque D Todd"

Claim this Profile
C
Challenges and approaches for the development of safer immunomodulatory biologics.
Jean G Sathish, Swaminathan Sethu, Marie-Christine Bielsky, Lolke de Haan, Neil S French, Marque D Todd

Nat Rev Drug Discov· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations regarding nonhuman primate use in safety assessment of biopharmaceuticals.
Lorrene A Buckley, Kathryn Chapman, Leigh Ann Burns-Naas, Marque D Todd, Pauline L Martin

Int J Toxicol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carcinogenicity assessments of biotechnology-derived pharmaceuticals: a review of approved molecules and best practice recommendations.
John L Vahle, Gregory L Finch, Shawn M Heidel, David N Hovland, Inge Ivens, Marque D Todd

Toxicol Pathol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and function of erythropoietin receptors in tumors: implications for the use of erythropoiesis-stimulating agents in cancer patients.
Angus M Sinclair, Marque D Todd, Kevin Forsythe, Susan J Knox, Steve Elliott

Cancer· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged treatment of human osteoarthritic chondrocytes with insulin-like growth factor-I stimulates proteoglycan synthesis but not proteoglycan matrix accumulation in alginate cultures.
Richard F Loeser, Marque D Todd, B Lynn Seely

J Rheumatol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis